在向癌症治疗中,利用双响应的聚合物微粒进行精确的氧化应激放大
Manseok Yang1, Sujin Kim1, Seungwon Jeong1
1Department of Bionanotechnology and Bioconvergence Engineering, Jeonbuk National University, Jeonju, Jeonbuk 54896, Korea.
Biomacromolecules
|December 9, 2024
概括
这项研究引入了新型的聚合物微粒,产生活性氧物种 (ROS) 和耗尽谷氨 (GSH) 以选择性杀死癌细胞. 针对性交付提高了疗效,并在临床前模型中降低了毒性.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 癌细胞表现出改变的氧化还原平衡,使它们容易受到氧化应激.
- 针对这种不平衡提供了选择性癌症治疗的策略.
研究的目的:
- 开发一种新的治疗策略,将反应性氧物种 (ROS) 生成和谷氨 (GSH) 枯竭结合起来,用于选择性癌症细胞死亡.
- 创建氧化应激增强聚合物 (pCB) 微粒,用于向药物输送和增强抗癌疗效.
主要方法:
- 开发包装ROS生成剂和GSH降低视网膜酸原药 (BRDP) 的pCB小粒.
- 用Arg-Gly-Asp (RGD) 来对瘤过度表达整合素的向输送的微粒的表面功能化.
- 在老鼠异种移植模型中评估细胞积累,抗癌疗效和毒性.
主要成果:
- pCB微粒成功封装并提供了ROS生成器和减少GSH的药物.
- 装饰着RGD的菌体在瘤部位显示出显著的积累.
- 在体内观察到增强的抗癌疗效,对正常组织没有明显的毒性.
结论:
- 开发的氧化应激增强聚合物微粒代表了一种新且有效的抗癌治疗方法.
- 整合多种瘤特异性触发物和ROS介导机制,为癌症治疗提供了一个有希望的策略.
相关概念视频
Electron Transport Chain: Complex I and II
11.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.5K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


